Major tumor-promoting and immunosuppressive functions of myeloid cells include release of growth factors such as MMP-9 and oncostatin M which induce upregulation of VEGF and HIF-2alpha pathways leading to neo-angiogenesis, hypoxia, and ultimately cancer invasiveness and progression (14, 27, 28). This evidence concerns the gene EPAS1 and cancer.